Patent · US Active

Compounds

US8951999B2 · kind B2 · utility

1Cited by
3References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 20, 2010
Grant dateFeb 10, 2015
Priority date
Expiry dateAug 15, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to compounds of formula I,their use as inhibitors of the microsomal prostaglandin E2 synthase-1 (mPGES-1), pharmaceutical compositions containing them, and their use as medicaments for the treatment and/or prevention of inflammatory diseases and associated conditions such as inflammatory/nociceptive pain.A, M, R1, R2, R7, Ra, Rb, Q3, Q4, Q6, Z2, Z4, Z5, Z6 and W have meanings given in the description.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.